Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake

Phase 1

• Conditions: gastric cancer with peritoneal metastasis

• Registration Number: JPRN-UMIN000019206
• Lead Sponsor: The University of Tokyo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-01
• Study Completion: 2018-12-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Not provided

Exclusion Criteria

1) metastasis to distant organ sites other than the peritoneum, ovary or abdominal lymph nodes 2) other active concomitant malignancies 3) massive ascites which requires frequent drainage for palliation other severe medical conditions 4) contraindication for fluorouracil, levofolinate, oxaliplatin or paclitaxel 5) past or current severe heart disease 6) severe complications such as interstitial pneumonitis, pulmonary fibrosis, uncontrollable diabetes mellitus, renal failure or liver cirrhosis 7) pregnant or nursing women 8) judged to be unfit to participate in this study by investigators

Study & Design

• Study Type: Interventional
• Study Design: Not specified